fenclonine has been researched along with Atherosclerotic Parkinsonism in 3 studies
Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Delaville, C | 1 |
Navailles, S | 1 |
Benazzouz, A | 1 |
Silvestrini, B | 1 |
Lisciani, R | 1 |
Chase, TN | 1 |
1 review available for fenclonine and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Serotonergic mechanisms and extrapyramidal function in man.
Topics: 5-Hydroxytryptophan; Carbidopa; Cerebellar Diseases; Creutzfeldt-Jakob Syndrome; Down Syndrome; Extr | 1974 |
2 other studies available for fenclonine and Atherosclerotic Parkinsonism
Article | Year |
---|---|
Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
Topics: Animals; Benzylamines; Electrophysiological Phenomena; Extracellular Space; Fenclonine; Globus Palli | 2012 |
Experimental data suggesting an adrenergic mechanism in the production of parkinsonian symptoms.
Topics: 5-Hydroxytryptophan; Animals; Atropine; Clonidine; Female; Fenclonine; Imipramine; Male; Mice; Mice, | 1976 |